Par Claims Rival Misled Patients With Nasal Spray
Par Pharmaceuticals Inc. has filed suit against Fleming & Co. Pharmaceuticals, claiming the rival drug company infringed its patent and intentionally misled consumers with the marketing of its prescription nasal spray,...To view the full article, register now.
Already a subscriber? Click here to view full article